This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First Amendment’s protection of free speech.
Source: JAMA Online First
| Curriculum Vitae | Résumé |
This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First Amendment’s protection of free speech.
Source: JAMA Online First